Bio-Rad Laboratories - 40 Year Stock Price History | BIO

Historical daily share price chart and data for Bio-Rad Laboratories since 1980 adjusted for splits. The latest closing stock price for Bio-Rad Laboratories as of August 03, 2020 is 531.04.
  • The all-time high Bio-Rad Laboratories stock closing price was 535.60 on July 30, 2020.
  • The Bio-Rad Laboratories 52-week high stock price is 540.06, which is 1.7% above the current share price.
  • The Bio-Rad Laboratories 52-week low stock price is 309.38, which is 41.7% below the current share price.
  • The average Bio-Rad Laboratories stock price for the last 52 weeks is 389.43.
Bio-Rad Laboratories Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 419.6741 372.1600 535.6000 320.0100 531.0400 43.51%
2019 312.5637 228.0800 374.2000 224.3000 370.0300 59.34%
2018 277.5328 241.4200 326.1500 220.1000 232.2200 -2.70%
2017 219.5752 182.9100 271.3000 182.9100 238.6700 30.94%
2016 149.1690 136.1900 183.4600 123.9300 182.2800 31.46%
2015 137.5260 120.3500 151.9300 113.7700 138.6600 15.01%
2014 120.8765 122.6500 133.7300 106.4800 120.5600 -2.47%
2013 118.6682 107.4600 126.0000 107.4600 123.6100 17.67%
2012 102.7218 98.0800 114.2500 92.3000 105.0500 9.38%
2011 108.0200 105.3200 126.3400 87.5400 96.0400 -7.52%
2010 94.7088 97.8700 113.6300 81.5000 103.8500 7.66%
2009 78.5782 74.4700 100.4600 53.1000 96.4600 28.08%
2008 87.1254 99.9700 108.1000 61.5200 75.3100 -27.32%
2007 82.9541 82.2200 107.5700 67.6700 103.6200 25.57%
2006 68.9380 65.4500 84.0100 57.2500 82.5200 26.10%
2005 55.5089 57.1700 66.9000 47.0600 65.4400 14.07%
2004 55.2252 58.4100 61.9000 50.0100 57.3700 -0.52%
2003 48.0377 38.2100 62.1500 33.4000 57.6700 49.02%
2002 39.7467 30.9000 50.5100 28.1250 38.7000 22.27%
2001 23.7924 16.0500 32.5250 15.0750 31.6500 99.06%
2000 12.9794 11.3100 16.7450 10.6250 15.9000 36.01%
1999 12.2611 10.3100 14.5000 9.4400 11.6900 11.33%
1998 13.1470 13.0600 16.8750 9.8750 10.5000 -19.60%
1997 13.5673 15.1900 16.3750 11.8100 13.0600 -12.93%
1996 14.6824 14.2067 18.3100 12.1250 15.0000 5.88%
1995 11.3630 9.1267 14.1667 8.4567 14.1667 53.15%
1994 6.4240 3.5000 9.6267 3.5000 9.2500 177.50%
1993 4.7750 5.7067 5.9167 3.3333 3.3333 -41.59%
1992 6.1821 6.4167 7.1267 5.3733 5.7067 -13.32%
1991 7.0525 6.0833 9.1667 5.5433 6.5833 6.76%
1990 5.8093 5.4167 7.6667 4.2067 6.1667 15.63%
1989 5.6551 5.7067 6.5433 4.7500 5.3333 -5.88%
1988 6.3804 5.2500 7.7067 4.9167 5.6667 11.48%
1987 7.6195 5.8733 10.6667 3.7500 5.0833 -11.59%
1986 5.9524 5.0556 7.6400 4.5556 5.7500 13.74%
1985 3.2334 2.1304 5.3067 2.1304 5.0556 137.31%
1984 2.2033 2.5007 2.5185 2.0741 2.1304 -14.81%
1983 2.3317 1.3511 2.8696 1.3511 2.5007 87.56%
1982 1.3124 1.5378 1.6104 0.8696 1.3333 -7.69%
1981 2.4659 2.9807 3.6667 1.2963 1.4444 -51.25%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $15.561B $2.312B
Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials, and to identify, analyze, and purify their components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment offers electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation, and amplification products and services. The Clinical Diagnostics segment provides control, autoimmune, diabetes, and blood virus testing products. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. The company is headquartered in Hercules, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $178.017B 33.44
Medtronic (MDT) Ireland $129.409B 21.02
Stryker (SYK) United States $72.454B 28.10
Boston Scientific (BSX) United States $53.973B 31.88
Lonza Group Ag (LZAGY) Switzerland $46.320B 0.00
Baxter (BAX) United States $43.728B 0.00
ResMed (RMD) United States $29.297B 46.24
EssilorLuxottica Societe Anonyme (ESLOY) France $28.981B 0.00
Terumo (TRUMY) Japan $28.862B 36.89
Zimmer Biomet Holdings (ZBH) United States $27.836B 17.51
Sunny Optical Technology (SNPTF) China $20.336B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.428B 0.00
Insulet (PODD) United States $12.829B 1271.00
Shandong Weigao Medical Polymer (SHWGF) China $12.301B 0.00
Quidel (QDEL) United States $11.863B 62.77
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
GN STORE NORD (GNNDY) Denmark $7.981B 40.68
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Perrigo (PRGO) Ireland $7.227B 12.93
Canopy Growth (CGC) Canada $6.779B 0.00
Hill-Rom Holdings (HRC) United States $6.471B 16.07
Haemonetics (HAE) United States $4.409B 26.48
Neogen (NEOG) United States $4.066B 67.94
GW Pharmaceuticals (GWPH) United Kingdom $3.963B 0.00
ICU Medical (ICUI) United States $3.828B 27.92
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.617B 0.00
Envista Holdings (NVST) United States $3.486B 23.77
Abcam (ABCZY) $3.456B 0.00
Agios Pharmaceuticals (AGIO) United States $3.132B 0.00
NuVasive (NUVA) United States $2.929B 23.51
National Vision Holdings (EYE) United States $2.568B 44.43
TG Therapeutics (TGTX) United States $2.157B 0.00
AtriCure (ATRC) United States $1.834B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.627B 0.00
Aphria (APHA) Canada $1.374B 0.00
NanoString Technologies (NSTG) United States $1.362B 0.00
MacroGenics (MGNX) United States $1.248B 0.00
Aurora Cannabis (ACB) Canada $1.176B 0.00
Cerus (CERS) United States $1.169B 0.00
OraSure Technologies (OSUR) United States $1.127B 226.88
Vapotherm (VAPO) United States $1.113B 0.00
Cardiovascular Systems (CSII) United States $1.075B 0.00
Meridian Bioscience (VIVO) United States $1.049B 39.50
PetIQ (PETQ) United States $1.036B 29.91
InMode (INMD) Israel $1.035B 21.86
Owens & Minor (OMI) United States $1.013B 26.80
Phibro Animal Health (PAHC) United States $0.938B 18.71
Quanterix (QTRX) United States $0.915B 0.00
Omeros (OMER) United States $0.699B 0.00
Zynex (ZYXI) United States $0.664B 57.94
Surmodics (SRDX) United States $0.643B 77.53
Eagle Pharmaceuticals (EGRX) United States $0.635B 45.48
BioLife Solutions (BLFS) United States $0.617B 175.73
VAREX IMAGING (VREX) United States $0.613B 15.22
LeMaitre Vascular (LMAT) United States $0.592B 36.21
Lantheus Holdings (LNTH) United States $0.536B 12.48
Viemed Healthcare (VMD) United States $0.421B 37.38
Cytosorbents (CTSO) United States $0.347B 0.00
HEXO (HEXO) $0.313B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.308B 0.00
Utah Medical Products (UTMD) United States $0.297B 25.47
Organigram Holdings (OGI) Canada $0.216B 0.00
Chimerix (CMRX) United States $0.193B 0.00
Female Health (VERU) United States $0.192B 0.00
Fonar (FONR) United States $0.159B 14.07
Exagen (XGN) United States $0.157B 0.00
Bovie Medical (APYX) United States $0.153B 0.00
Surface Oncology (SURF) United States $0.148B 0.00
Wound Management Technologies (SMTI) United States $0.132B 0.00
Liberty Health Sciences (LHSIF) Canada $0.126B 0.00
Rockwell Medical (RMTI) United States $0.119B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.116B 0.00
Capricor Therapeutics (CAPR) United States $0.114B 0.00
Chembio Diagnostics (CEMI) United States $0.112B 0.00
Evolus (EOLS) United States $0.110B 0.00
MTech Acquisition (KERN) United States $0.087B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.086B 0.00
Nephros (NEPH) United States $0.073B 0.00
United-Guardian (UG) United States $0.066B 15.34
Brainsway (BWAY) Israel $0.064B 0.00
Trinity Biotech (TRIB) Ireland $0.060B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Akers Biosciences Inc (AKER) United States $0.032B 0.00
FSD PHARMA INC (HUGE) Canada $0.032B 0.00
NF Energy Saving (BIMI) China $0.020B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
Senestech (SNES) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00